BSE filing, NSE: MBPARIKH. Summary written from the filing by ALFA Finder's alert engine.
Kalind Ltd: key numbers
- Share price
- ₹3.11
- Market cap
- ₹284.3 Cr
- Revenue (annual)
- ₹79.85 Cr
- Net profit (annual)
- ₹27.23 Cr
- P/E (TTM)
- 6.9×Sector 19.7×
- Promoter holding
- 10.09%-3.67% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kalind Ltd
All →Kalind Board Meeting Date
Kalind Ltd will hold a Board meeting on 31 October 2026 to update on and decide the ongoing preferential issue of 8,60,86,956 equity shares. In-principle approval from BSE is still awaited.
Kalind Other Announcement
Kalind Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR Regulations.
Kalind Annual General Meeting
Kalind Limited held its Annual General Meeting on September 29, 2026, passing resolutions including financial statement adoption and preferential share issuance.
Kalind Annual General Meeting
Kalind Limited issued a corrigendum to its 32nd AGM notice, withdrawing a previously proposed warrant issue. It replaced this with a new preferential equity issue.
- Value
- ₹99.00 Cr
Kalind Capital Structure Change
Kalind Limited's board approved a fresh preferential issue of 8.61 crore equity shares at ₹11.50 per share, raising ₹99 Crore, replacing a prior warrant proposal.
- Value
- ₹99.00 Cr
Kalind Board Meeting Date
Kalind Limited scheduled a board meeting for September 17, 2026, to reconsider and potentially amend previously approved fund-raising proposals.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.